| Literature DB >> 22349104 |
David A Bergin1, Killian Hurley, Noel G McElvaney, Emer P Reeves.
Abstract
Alpha-1 antitrypsin (AAT) has long been thought of as an important anti-protease in the lung where it is known to decrease the destructive effects of major proteases such as neutrophil elastase. In recent years, the perception of this protein in this simple one dimensional capacity as an anti-protease has evolved and it is now recognised that AAT has significant anti-inflammatory properties affecting a wide range of inflammatory cells, leading to its potential therapeutic use in a number of important diseases. This present review aims to discuss the described anti-inflammatory actions of AAT in modulating key immune cell functions, delineate known signalling pathways and specifically to identify the models of disease in which AAT has been shown to be effective as a therapy.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22349104 DOI： 10.1007/s00005-012-0162-5
Source DB: PubMed Journal: Arch Immunol Ther Exp (Warsz) ISSN： 0004-069X Impact factor: 4.291